35
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Increases in Health-Related Workplace Absenteeism Among Workers in Essential Critical Infrastructure Occupations During the COVID-19 Pandemic — United States, March–April 2020

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          During a pandemic, syndromic methods for monitoring illness outside of health care settings, such as tracking absenteeism trends in schools and workplaces, can be useful adjuncts to conventional disease reporting ( 1 , 2 ). Each month, CDC’s National Institute for Occupational Safety and Health (NIOSH) monitors the prevalence of health-related workplace absenteeism among currently employed full-time workers in the United States, overall and by demographic and occupational subgroups, using data from the Current Population Survey (CPS).* This report describes trends in absenteeism during October 2019–April 2020, including March and April 2020, the period of rapidly accelerating transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). Overall, the prevalence of health-related workplace absenteeism in March and April 2020 were similar to their 5-year baselines. However, compared with occupation-specific baselines, absenteeism among workers in several occupational groups that define or contain essential critical infrastructure workforce † categories was significantly higher than expected in April. Significant increases in absenteeism were observed in personal care and service § (includes child care workers and personal care aides); healthcare support ¶ ; and production** (includes meat, poultry, and fish processing workers). Although health-related workplace absenteeism remained relatively unchanged or decreased in other groups, the increase in absenteeism among workers in occupational groups less able to avoid exposure to SARS-CoV-2 ( 3 ) highlights the potential impact of COVID-19 on the essential critical infrastructure workforce because of the risks and concerns of occupational transmission of SARS-CoV-2. More widespread and complete collection of occupational data in COVID-19 surveillance is required to fully understand workers’ occupational risks and inform intervention strategies. Employers should follow available recommendations to protect workers’ health. CPS is a monthly national survey of approximately 54,000 households conducted by the U.S. Census Bureau for the Bureau of Labor Statistics. The survey, the nation’s primary source of labor force statistics, collects information on employment, demographic, and other characteristics of the civilian, noninstitutionalized population aged ≥16 years. Data on all sample household members are collected from a single respondent by trained interviewers through in-person or telephone interviews using a standardized questionnaire. †† Monthly point estimates and 95% confidence intervals (CIs) of the prevalence of health-related workplace absenteeism among all full-time workers during October 2019 to April 2020 were calculated and compared with an epidemic threshold defined as the upper 95% confidence limit of a historical baseline that represents the expected value and was established using data from the previous 5 years, aggregated by month. §§ Estimates with lower 95% confidence limits that exceeded the epidemic threshold were considered significantly higher than expected; this conservative method helps account for multiple comparisons. Comparisons for which the point estimate, but not the lower 95% confidence limit, exceeds the epidemic threshold indicate possible increases and warrant further scrutiny. For such occurrences, the Z-test for independent proportions was used to further test the significance of differences in observed versus expected absenteeism. Results of these post hoc tests with a significance level of p<0.05 were considered equivocal evidence of increased absenteeism. Estimates were also calculated for 22 civilian occupational subgroups ¶¶ and compared with their occupation-specific epidemic thresholds. A full-time worker was defined as an employed person aged ≥16 years who reported usually working at least 35 hours per week for all jobs combined. Health-related workplace absenteeism was defined as working <35 hours during the reference week because of the worker’s own illness, injury, or other medical problem. Based on special guidance provided to CPS interviewers by the Bureau of Labor Statistics in March and April 2020, this categorization also applied to persons who indicated they were under quarantine or self-isolating because of exposure to COVID-19.*** Because the CPS questions refer to 1 week of each month, absenteeism during the other weeks is not measured. These 1-week measures are intended to be representative of all weeks of the month during which they occur. All analyses were weighted using the CPS composite weight and estimates of all standard errors were adjusted to account for the complex design of the CPS sample. Analyses were performed using SAS statistical software (version 9.4; SAS Institute). During October 2019–February 2020, point estimates of the prevalence of health-related workplace absenteeism among all full-time workers remained at or below the epidemic threshold. In March and April 2020, these estimates exceeded the epidemic threshold, although not significantly (Figure). The Z-test for independent proportions also did not indicate a statistically significant increase in absenteeism in March (p = 0.18) or April (p = 0.06). FIGURE Prevalence* of health-related workplace absenteeism † reported by full-time workers § relative to an epidemic threshold, ¶ overall (A)** and by occupational subgroup (B, C, D) †† , §§ , ¶¶ — Current Population Survey, United States, October 2019–April 2020 * Error bars represent 95% confidence intervals for point estimates. † Defined as working <35 hours during the reference week because of illness, injury, or other medical issue. § Employed persons who usually work ≥35 hours per week at all jobs combined. ¶ Epidemic threshold is the upper 95% confidence limit for expected values; expected values are based on monthly averages for the previous 5 years. The expected baseline and epidemic threshold are shown for the entire October–September surveillance period to illustrate expected seasonality. ** All occupations combined. †† Personal care and service occupations include 2010 Census occupation codes 4300–4650. §§ Healthcare support occupations include 2010 Census occupation codes 3600–3655. ¶¶ Production occupations include 2010 Census occupation codes 7700–8750. The figure is a combination of four line graphs showing the U.S. prevalence of health-related workplace reported by full-time workers, relative to an epidemic threshold, overall and by the personal care and service, healthcare support, and production occupational subgroups, based on data from the Current Population Survey during October 2019–April 2020. In April, absenteeism among the following occupational subgroups significantly exceeded their occupation-specific epidemic thresholds based on the nonoverlapping CI criterion: personal care and service, including childcare workers and personal care aides (5.1% [95% CI = 3.5–6.7] observed, versus 2.1% [95% CI = 1.7–2.6] expected); healthcare support (5.0% [95% CI = 3.1–6.8] versus 2.4% [95% CI = 1.9–2.8]; and production, including meat, poultry, and fish processing workers (3.7% [95% CI = 2.7–4.7] versus 2.3% [95% CI = 2.0–2.6]) (Figure) (Table). Based on the Z-test for independent proportions, prevalence in April might also have been higher among transportation and material moving occupations, ††† which include bus drivers and subway and streetcar workers (3.6% [95% CI = 2.6–4.6] versus 2.5% [95% CI = 2.2–2.9], p = 0.040), and healthcare practitioner and technical occupations §§§ (2.8% [95% CI = 2.0–3.6] versus 1.9% [95% CI = 1.6–2.1], p = 0.017). Absenteeism prevalence either declined or remained flat for all other occupational groups. Absenteeism was not significantly higher than expected for any other group in any month during October 2019–February 2020. TABLE Monthly prevalence of health-related workplace absenteeism* among full-time workers, † by occupational group — Current Population Survey, United States, October 2019–April 2020 Occupational group Weighted % (95% CI) Oct–Dec 2019 Jan–Apr 2020 Oct Nov Dec Jan Feb Mar Apr Total 1.9 (1.8–2.0)§ 1.9 (1.8–2.0) 2.2 (2.0–2.4) 2.4 (2.3–2.6) 2.4 (2.2–2.6) 2.4 (2.2–2.7)§ 2.2 (1.9–2.5)§ Personal care and service 2.4 (1.6–3.2) 2.1 (1.4–2.7) 1.9 (1.1–2.6) 3.2 (2.0–4.4) 2.6 (1.4–3.9) 3.0 (1.4–4.6) 5.1 (3.5–6.7)¶ Healthcare support 2.1 (1.1–3.1) 1.8 (1.0–2.5) 2.4 (1.6–3.2) 3.2 (1.6–4.8) 2.5 (1.2–3.9) 3.3 (2.1–4.5) 5.0 (3.1–6.8)¶ Production 2.2 (1.5–2.9) 2.2 (1.6–2.9) 2.5 (2.0–3.1) 2.8 (2.3–3.4) 2.6 (2.2–3.1) 3.5 (2.5–4.4)§ 3.7 (2.7–4.7)¶ Transportation and material moving 2.9 (2.1–3.6)§ 2.2 (1.4–3.0) 2.9 (2.4–3.5) 2.8 (1.8–3.8) 3.1 (2.4–3.8) 3.1 (2.3–3.9) 3.6 (2.6–4.6)** Building and grounds cleaning and maintenance 1.9 (1.0–2.8) 1.9 (0.9–2.9) 2.9 (2.1–3.8) 2.9 (1.7–4.2) 3.4 (2.4–4.4) 3.2 (1.9–4.5) 3.3 (2.1–4.5) Food preparation and serving related 2.1 (1.3–2.9) 2.2 (1.3–3.1) 2.7 (1.7–3.6) 2.7 (1.5–3.9) 3.0 (1.9–4.0) 2.8 (1.7–3.8) 3.1 (1.1–5.1) Construction and extraction 1.4 (0.9–2.0) 1.6 (1.0–2.2) 2.2 (1.7–2.7) 3.1 (2.0–4.1)§ 2.5 (1.7–3.2) 2.3 (1.4–3.1) 2.9 (1.8–4.1)§ Healthcare practitioner and technical 2.3 (1.8–2.8) 2.0 (1.5–2.5) 2.3 (1.7–2.9) 2.4 (1.6–3.2) 2.5 (1.9–3.0) 2.1 (1.5–2.7) 2.8 (2.0–3.6)** Farming, fishing, and forestry 1.1 (0.0–2.4) 1.4 (0.0–3.5) 1.6 (0.1–3.2) 4.2 (2.1–6.2)§ 3.7 (0.9–6.5) 2.6 (0.0–5.4)§ 2.6 (0.0–6.5) Office and administrative support 2.6 (2.1–3.1)§ 2.4 (2.1–2.7) 2.7 (2.3–3.1) 3.0 (2.2–3.7) 2.5 (2.1–2.9) 3.0 (2.5–3.5) 2.5 (1.8–3.1) Legal occupations 2.0 (0.7–3.3) 1.0 (0.1–1.9) 1.5 (0.6–2.5) 2.9 (1.5–4.3)§ 2.7 (1.0–4.3) 0.9 (0.1–1.8) 2.3 (0.7–3.8) Sales and related 1.7 (1.3–2.1)§ 2.1 (1.6–2.7)** 2.0 (1.5–2.6) 2.0 (1.6–2.5) 2.3 (1.5–3.1)§ 2.1 (1.7–2.6) 2.1 (1.6–2.6) Protective service 2.7 (1.4–3.9)§ 2.4 (1.3–3.5)§ 2.9 (1.6–4.1) 3.3 (2.2–4.3)§ 2.6 (1.8–3.3)§ 2.3 (1.6–3.1) 2.1 (1.3–3.0) Installation, maintenance and repair 2.4 (1.6–3.1) 2.4 (1.6–3.2) 1.9 (1.2–2.6) 1.8 (1.0–2.7) 2.8 (2.1–3.5) 3.5 (2.3–4.7)§ 2.0 (1.2–2.9) Education, training, and library 1.5 (1.1–2.0) 2.3 (1.7–2.8)** 2.7 (1.9–3.4)§ 2.7 (2.1–3.2)§ 2.5 (1.9–3.0) 2.2 (1.5–2.9) 1.5 (0.8–2.3) Architecture and engineering 0.8 (0.0–1.7) 1.3 (0.4–2.2) 1.4 (0.6–2.2) 2.5 (1.3–3.6) 1.5 (0.7–2.4) 2.4 (1.3–3.4)§ 1.4 (0.6–2.1) Arts, design, entertainment, sports, and media 2.1 (0.7–3.5) 2.1 (0.9–3.3) 2.3 (0.7–3.9) 2.0 (0.7–3.3) 1.6 (0.9–2.4) 2.5 (0.6–4.4) 1.4 (0.3–2.5) Business and financial operations 1.5 (1.1–2.0) 1.3 (0.7–1.9) 2.1 (1.5–2.6) 2.5 (1.8–3.1) 2.4 (1.9–2.8)§ 1.6 (0.9–2.2) 1.2 (0.7–1.8) Computer and mathematical science 1.4 (0.8–2.0) 0.8 (0.3–1.2) 1.6 (0.9–2.2) 1.6 (1.0–2.3) 2.2 (1.3–3.1) 2.0 (1.2–2.8)§ 1.1 (0.5–1.8) Community and social service 1.9 (0.7–3.1) 2.5 (1.4–3.6) 1.8 (1.0–2.5) 1.6 (0.8–2.4) 2.3 (1.1–3.4) 3.1 (1.9–4.2) 1.0 (0.0–2.2) Management 1.1 (0.8–1.4) 1.3 (0.9–1.6) 1.7 (1.4–1.9) 1.3 (1.0–1.6) 1.6 (1.3–1.9) 1.6 (1.3–2.0) 0.9 (0.6–1.2) Life, physical, and social science 1.9 (0.5–3.4) 2.8 (1.0–4.5) 2.4 (0.8–4.0) 2.9 (1.4–4.4) 2.5 (1.0–3.9) 1.2 (0.3–2.1) 0.5 (0.0–1.2) Abbreviation: CI = confidence interval. * Defined as working <35 hours during the reference week because of illness, injury or other medical issue. † Defined as employed persons who usually work ≥35 hours per week at all jobs combined. § Point estimate, but not its lower 95% confidence limit, exceeded an epidemic threshold defined as the upper 95% confidence limit of the expected value, based on monthly average for the previous 5 years, and p-value for post hoc observed versus expected comparison using Z-test for independent proportion ≥0.05. ¶ Significantly exceeded the epidemic threshold (i.e., lower 95% confidence limit of the point estimate exceeded the epidemic threshold). ** Point estimate, but not its lower 95% confidence limit, exceeded the epidemic threshold and p-value for post hoc observed versus expected comparison using Z-test for independent proportion <0.05. Discussion These findings indicate that although the overall impact of the COVID-19 pandemic on health-related workplace absenteeism among full-time workers in March and April 2020 was minor, during April 2020, absenteeism was significantly higher than expected among several occupational groups that either define or contain infrastructure workforce categories deemed essential and critical (health care support occupations, personal care and service occupations, and production occupations) based on their 5-year historical baselines. Many essential critical infrastructure jobs inherently involve prolonged close contact with patients, the general public, or coworkers ( 3 ). The workers in these occupational groups are also likely to have had to continue to be physically present in their workplaces during March and April and could not avoid exposure by, for example, working from home. For both reasons, workers in these essential critical infrastructure occupations are likely to be at increased risk for occupational exposure to SARS-CoV-2. Equivocal evidence of increased absenteeism in April was found for workers in the transportation and material moving and healthcare practitioner and technical occupations; these occupations are also part of the essential critical infrastructure workforce, and therefore are also likely to be at increased risk for occupational exposure to SARS-CoV-2 for the same reasons. Health-related workplace absenteeism correlates well with the prevalence of influenza-like illness ¶¶¶ ( 4 ), making it a useful measure of the impact of influenza pandemics or seasonal influenza epidemics on the working population ( 1 , 2 ). Whether this is true of COVID-19 is not yet known. Overall, absenteeism among the employed full-time workforce did not increase in conjunction with the incidence of COVID-19 in March and April; estimates for those months were similar to the 5-year baseline. This finding might be because of increased remote work or telework during these 2 months by those who could do so after implementation of the stay-at-home or shelter-in-place of residence recommendations ( 5 ), because of workplace control measures implemented to reduce exposures, or because the population most likely to experience symptomatic illness with COVID-19, persons aged >70 years ( 6 ), did not overlap substantially with the working population. However, the increase in health-related workplace absenteeism specifically among workers in certain occupational groups less able to avoid exposure to SARS-CoV-2 while such absenteeism remained relatively flat or decreased in other occupational groups highlights the potential impact of COVID-19 on the essential critical infrastructure workforce caused by the risks and concerns of occupational transmission of SARS-CoV-2. The findings in this report are subject to at least seven limitations. First, operationalized, health-related workplace absenteeism includes absences caused by injuries, preventive care, and illnesses unrelated to COVID-19, as well as quarantine-associated absences, which could attenuate or confound absenteeism’s putative relation to COVID-19 incidence. Second, data from the March and April surveys were adversely affected by the pandemic’s impact on the U.S. Census Bureau’s survey operations, resulting in substantial and nonrandom reductions in response rates across respondent groups. However, the Bureau of Labor Statistics was able to obtain estimates that met standards for accuracy and reliability. Third, monthly absenteeism estimates are based on 1-week measures and could have underestimated or overestimated the actual prevalence for any given month in a way that is not reflected in the 95% CIs. Fourth, the nature of the CPS data only allows for calculation of health-related absenteeism among full-time workers; patterns of absenteeism might be different among part-time workers. Fifth, the occupational subgroups analyzed include multiple occupations with heterogeneous levels of exposure to patients, clients, or members of the public with COVID-19. Sixth, prevalences of absenteeism in this report are not adjusted to control for the effect of potential sociodemographic confounders such as age, sex, race, or ethnicity. Finally, these national analyses might have failed to detect localized increases in absenteeism in specific geographic regions. These findings are consistent with those from public health surveillance and field investigations suggesting that certain groups of workers might be at increased risk for SARS-CoV-2 infection because of their work during the pandemic, including health care personnel ( 7 , 8 ) and food production workers ( 9 ), among others ( 10 ). CDC and Occupational Safety and Health Administration guidance for protecting essential critical infrastructure workers is available and should be followed by their employers.**** In addition, improved surveillance is needed to monitor industry-specific and occupation-specific morbidity and mortality in this and future pandemics. In May 2020, CDC revised its COVID-19 Case Report Form to record certain health care–specific occupations, as well as limited information on suspected workplace exposures and settings for essential critical infrastructure workers. †††† Collection of additional information on work characteristics §§§§ might help better describe the occupational risk and impact of COVID-19 and inform intervention strategies. Summary What is already known about this topic? Syndromic methods for monitoring illness outside health care settings, such as tracking absenteeism trends in schools and workplaces, can be useful adjuncts to conventional disease reporting in the pandemic setting. What is added by this report? Whereas the overall impact of COVID-19 on health-related workplace absenteeism in March and April was minor, increases in absenteeism in personal care and service, healthcare support, and production occupations, groups that contain or define essential critical infrastructure workforce categories, highlight the risks and concerns surrounding occupational transmission of SARS-CoV-2. What are the implications for public health practice? Collection of additional occupational data in COVID-19 surveillance might help better understanding of the occupational risk and impact of COVID-19 and identify intervention opportunities.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Age-dependent effects in the transmission and control of COVID-19 epidemics

          The COVID-19 pandemic has shown a markedly low proportion of cases among children1-4. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea. We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10- to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years. Accordingly, we find that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. Our age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structures-such as many low-income countries-the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020

            As of April 9, 2020, the coronavirus disease 2019 (COVID-19) pandemic had resulted in 1,521,252 cases and 92,798 deaths worldwide, including 459,165 cases and 16,570 deaths in the United States ( 1 , 2 ). Health care personnel (HCP) are essential workers defined as paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious materials ( 3 ). During February 12–April 9, among 315,531 COVID-19 cases reported to CDC using a standardized form, 49,370 (16%) included data on whether the patient was a health care worker in the United States; including 9,282 (19%) who were identified as HCP. Among HCP patients with data available, the median age was 42 years (interquartile range [IQR] = 32–54 years), 6,603 (73%) were female, and 1,779 (38%) reported at least one underlying health condition. Among HCP patients with data on health care, household, and community exposures, 780 (55%) reported contact with a COVID-19 patient only in health care settings. Although 4,336 (92%) HCP patients reported having at least one symptom among fever, cough, or shortness of breath, the remaining 8% did not report any of these symptoms. Most HCP with COVID-19 (6,760, 90%) were not hospitalized; however, severe outcomes, including 27 deaths, occurred across all age groups; deaths most frequently occurred in HCP aged ≥65 years. These preliminary findings highlight that whether HCP acquire infection at work or in the community, it is necessary to protect the health and safety of this essential national workforce. Data from laboratory-confirmed COVID-19 cases voluntarily reported to CDC from 50 states, four U.S. territories and affiliated islands, and the District of Columbia, during February 12–April 9 were analyzed. Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship during January and February were excluded. Public health departments report COVID-19 cases to CDC using a standardized case report form* that collects information on patient demographics, whether the patient is a U.S. health care worker, symptom onset date, specimen collection dates, history of exposures in the 14 days preceding illness onset, COVID-19 symptomology, preexisting medical conditions, and patient outcomes, including hospitalization, intensive care unit (ICU) admission, and death. HCP patient health outcomes, overall and stratified by age, were classified as hospitalized, hospitalized with ICU admission, and deaths. The lower bound of these percentages was estimated by including all cases within each age group in the denominators. Upper bounds were estimated by including only those cases with known information on each outcome as denominators. Data reported to CDC are preliminary and can be updated by health departments over time. The upper quartile of the lag between onset date and reporting to CDC was 10 days. Because submitted forms might have missing or unknown information at the time of report, all analyses are descriptive, and no statistical comparisons were performed. Stata (version 15.1; StataCorp) and SAS (version 9.4; SAS Institute) were used to conduct all analyses. Among 315,531 U.S. COVID-19 cases reported to CDC during February 12–April 9, data on HCP occupational status were available for 49,370 (16%), among whom 9,282 (19%) were identified as HCP (Figure). Data completeness for HCP status varied by reporting jurisdiction; among 12 states that included HCP status on >80% of all reported cases and reported at least one HCP patient, HCP accounted for 11% (1,689 of 15,194) of all reported cases. FIGURE Daily number of COVID-19 cases, by date of symptom onset, among health care personnel and non-health care personnel (N = 43,986)* , † — United States, February 12–April 9, 2020 Abbreviation: COVID-19 = coronavirus disease 2019. * Onset date was calculated for 5,892 (13%) cases where onset date was missing. This was done by subtracting 4 days (median interval from symptom onset to specimen collection date) from the date of earliest specimen collection. Cases with unknown onset and specimen collection dates were excluded. † Ten-day window is used to reflect the upper quartile in lag between the date of symptom onset and date reported to CDC. The figure is a bar chart showing the number of reported COVID-19 cases among health care personnel and non-health care personnel (N = 43,986), by date of illness onset, in the United States during February 12–April 9, 2020. Among the 8,945 (96%) HCP patients reporting age, the median was 42 years (IQR = 32–54 years); 6,603 (73%) were female (Table 1). Among the 3,801 (41%) HCP patients with available data on race, a total of 2,743 (72%) were white, 801 (21%) were black, 199 (5%) were Asian, and 58 (2%) were other or multiple races. Among 3,624 (39%) with ethnicity specified, 3,252 (90%) were reported as non-Hispanic/Latino and 372 (10%) as Hispanic/Latino. At least one underlying health condition † was reported by 1,779 (38%) HCP patients with available information. TABLE 1 Demographic characteristics, exposures, symptoms, and underlying health conditions among health care personnel with COVID-19 (N = 9,282) — United States, February 12–April 9, 2020 Characteristic (no. with available information) No. (%) Age group (yrs) (8,945) 16–44 4,898 (55) 45–54 1,919 (21) 55–64 1,620 (18) ≥65 508 (6) Sex (9,067) Female 6,603 (73) Male 2,464 (27) Race (3,801) Asian 199 (5) Black 801 (21) White 2,743 (72) Other* 58 (2) Ethnicity (3,624) Hispanic/Latino 372 (10) Non-Hispanic/Latino 3,252 (90) Exposures†,§ (1,423) Only health care exposure 780 (55) Only household exposure 384 (27) Only community exposure 187(13) Multiple exposure settings¶ 72 (5) Symptoms reported§,** (4,707) Fever, cough, or shortness of breath†† 4,336 (92) Cough 3,694 (78) Fever§§ 3,196 (68) Muscle aches 3,122 (66) Headache 3,048 (65) Shortness of breath 1,930 (41) Sore throat 1,790 (38) Diarrhea 1,507 (32) Nausea or vomiting 923 (20) Loss of smell or taste¶¶ 750 (16) Abdominal pain 612 (13) Runny nose 583 (12) Any underlying health condition§,*** (4,733) 1,779 (38) Abbreviation: COVID-19 = coronavirus disease 2019. * “Other” includes patients who were identified as American Indian or Alaska Native (16), Native Hawaiian or Other Pacific Islander (22), or two or more races (20). † Cases were included in the denominator if the patient reported a known contact with a laboratory-confirmed COVID-19 patient within the 14 days before illness onset in a health care, household, or community setting. § Responses include data from standardized fields supplemented with data from free-text fields. ¶ Includes all patients with contact reported in more than one of these settings: health care, household, and community. ** Cases were included in the denominator if the patient had a known symptom status for fever, cough, shortness of breath, nausea or vomiting, and diarrhea. HCP with mild or asymptomatic infections might have been less likely to be tested, thus less likely to be reported. †† Includes all patients with at least one of these symptoms. §§ Patients were included if they had information for either measured or subjective fever variables and were considered to have a fever if “yes” was indicated for either variable. ¶¶ Symptom data on loss of smell or taste was extracted only from free-text symptom fields, thus the proportion with this symptom is likely an underestimate. *** Preexisting medical conditions and other risk factors (yes, no, or unknown) included the following: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease, and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease. Among 1,423 HCP patients who reported contact with a laboratory-confirmed COVID-19 patient in either health care, household, or community settings, 780 (55%) reported having such contact only in a health care setting within the 14 days before their illness onset; 384 (27%) reported contact only in a household setting; 187 (13%) reported contact only in a community setting; 72 (5%) reported contact in more than one of these settings. Among HCP patients with data available on a core set of signs and symptoms, § a total of 4,336 (92%) reported having at least one of fever, cough, shortness of breath. Two thirds (3,122, 66%) reported muscle aches, and 3,048 (65%) reported headache. Loss of smell or taste was written in for 750 (16%) HCP patients as an “other” symptom. Among HCP patients with data available on age and health outcomes, 6,760 (90%) were not hospitalized, 723 (8%–10%) were hospitalized, 184 (2%–5%) were admitted to an ICU, and 27 (0.3%–0.6%) died (Table 2). Although only 6% of HCP patients were aged ≥65 years, 10 (37%) deaths occurred among persons in this age group. TABLE 2 Hospitalizations,* intensive care unit (ICU) admissions, † and deaths, § by age group among health care personnel with COVID-19 — United States, February 12–April 9, 2020 Age group¶ (yrs) (no. of cases) Outcome, no. (%)** Hospitalization†† ICU admission Death 16–44 (4,898) 260 (5.3–6.4) 44 (0.9–2.2) 6 (0.1–0.3) 45–54 (1,919) 178 (9.3–11.1) 51 (2.7–6.3) 3 (0.2–0.3) 55–64 (1,620) 188 (11.6–13.8) 54 (3.3–7.5) 8 (0.5–1.0) ≥65 (508) 97 (19.1–22.3) 35 (6.9–16.0) 10 (2.0–4.2) Total (8,945) 723 (8.1–9.7) 184 (2.1–4.9) 27 (0.3–0.6) Abbreviation: COVID-19 = coronavirus disease 2019. * Hospitalization status known for 7,483 (84%) patients. † ICU status known for 3,739 (42%) patients. § Death outcomes known for 4,407 (49%) patients. ¶ Age status known for 8,945 (96%) patients. ** Lower bound of range = number of persons hospitalized, admitted to ICU, or who died among total in age group; upper bound of range = number of persons hospitalized, admitted to ICU, or who died among total in age group with known hospitalization status, ICU admission status, or death. †† Hospitalization status includes hospitalization with or without ICU admission. Discussion As of April 9, 2020, a total of 9,282 U.S. HCP with confirmed COVID-19 had been reported to CDC. This is likely an underestimation because HCP status was available for only 16% of reported cases nationwide. HCP with mild or asymptomatic infections might also have been less likely to be tested, thus less likely to be reported. Overall, only 3% (9,282 of 315,531) of reported cases were among HCP; however, among states with more complete reporting of HCP status, HCP accounted for 11% (1,689 of 15,194) of reported cases. The total number of COVID-19 cases among HCP is expected to rise as more U.S. communities experience widespread transmission. Compared with reports of COVID-19 patients in the overall populations of China and Italy ( 4 , 5 ), reports of HCP patients in the United States during February 12–April 9 were slightly younger, and a higher proportion were women; this likely reflects the age and sex distributions among the U.S. HCP workforce. Race and ethnicity distributions among HCP patients reported to CDC are different from those in the overall U.S. population but are more similar to those in the HCP workforce. ¶ , ** Among HCP patients who reported having contact with a laboratory-confirmed COVID-19 patient in health care, household, or community settings, the majority reported contact that occurred in health care settings. However, there were also known exposures in households and in the community, highlighting the potential for exposure in multiple settings, especially as community transmission increases. Further, transmission might come from unrecognized sources, including presymptomatic or asymptomatic persons ( 6 , 7 ). Together, these exposure possibilities underscore several important considerations for prevention. Done alone, contact tracing after recognized occupational exposures likely will fail to identify many HCP at risk for developing COVID-19. Additional measures that will likely reduce the risk for infected HCP transmitting the virus to colleagues and patients include screening all HCP for fever and respiratory symptoms at the beginning of their shifts, prioritizing HCP for testing, and ensuring options to discourage working while ill (e.g., flexible and nonpunitive medical leave policies). Given the evidence for presymptomatic and asymptomatic transmission ( 7 ), covering the nose and mouth (i.e., source control) is recommended in community settings where other social distancing measures are difficult to maintain. †† Assuring source control among all HCP, patients, and visitors in health care settings is another promising strategy for further reducing transmission. Even if everyone in a health care setting is covering their nose and mouth to contain their respiratory secretions, it is still critical that, when caring for patients, HCP continue to wear recommended personal protective equipment (PPE) (e.g., gown, N95 respirator [or facemask if N95 is not available], eye protection, and gloves for COVID-19 patient care). Training of HCP on preventive measures, including hand hygiene and PPE use, is another important safeguard against transmission in health care settings. Among HCP with COVID-19 whose age status was known, 8%–10% were reported to be hospitalized. This is lower than the 21%–31% of U.S. COVID-19 cases with known hospitalization status described in a recent report ( 8 ) and might reflect the younger median age (42 years) of HCP patients compared with that of reported COVID-19 patients overall, as well as prioritization of HCP for testing, which might identify less severe illness. Similar to earlier findings ( 8 ), increasing age was associated with a higher prevalence of severe outcomes, although severe outcomes, including death, were observed in all age groups. Preliminary estimates of the prevalence of underlying health conditions among all patients with COVID-19 reported to CDC through March 2020 ( 9 ) suggested that 38% had at least one underlying condition, the same percentage found in this HCP patient population. Older HCP or those with underlying health conditions ( 8 , 9 ) should consider consulting with their health care provider and employee health program to better understand and manage their risks regarding COVID-19. The increased prevalence of severe outcomes in older HCP should be considered when mobilizing retired HCP to increase surge capacity, especially in the face of limited PPE availability §§ ; one consideration is preferential assignment of retired HCP to lower-risk settings (e.g., telemedicine, administrative assignments, or clinics for non–COVID-19 patients). The findings in this report are subject to at least five limitations. First, approximately 84% of patients were missing data on HCP status. Thus, the number of cases in HCP reported here must be considered a lower bound because additional cases likely have gone unidentified or unreported. Second, among cases reported in HCP, the amount of missing data varied across demographic groups, exposures, symptoms, underlying conditions, and health outcomes; cases with available information might differ systematically from those without available information. Therefore, additional data are needed to confirm findings about the impact of potentially important factors (e.g., disparities in race and ethnicity or underlying health conditions among HCP). Third, additional time will be necessary for full ascertainment of outcomes, such as hospitalization status or death. Fourth, details of occupation and health care setting were not routinely collected through case-based surveillance and, therefore, were unavailable for this analysis. Finally, among HCP patients who reported contact with a confirmed COVID-19 patient in a health care setting, the nature of this contact, including whether it was with a patient, visitor, or other HCP, and the details of potential occupational exposures, including whether HCP were unprotected (i.e., without recommended PPE) or were present during high risk procedures (e.g., aerosol-generating procedures) are unknown ( 10 ). It is critical to make every effort to ensure the health and safety of this essential national workforce of approximately 18 million HCP, both at work and in the community. Surveillance is necessary for monitoring the impact of COVID-19-associated illness and better informing the implementation of infection prevention and control measures. Improving surveillance through routine reporting of occupation and industry not only benefits HCP, but all workers during the COVID-19 pandemic. Summary What is already known about this topic? Limited information is available about COVID-19 infections among U.S. health care personnel (HCP). What is added by this report? Of 9,282 U.S. COVID-19 cases reported among HCP, median age was 42 years, and 73% were female, reflecting these distributions among the HCP workforce. HCP patients reported contact with COVID-19 patients in health care, household, and community settings. Most HCP patients were not hospitalized; however, severe outcomes, including death, were reported among all age groups. What are the implications for public health practice? It is critical to ensure the health and safety of HCP, both at work and in the community. Improving surveillance through routine reporting of occupation and industry not only benefits HCP, but all workers during the COVID-19 pandemic.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020

              On February 26, 2020, the first U.S. case of community-acquired coronavirus disease 2019 (COVID-19) was confirmed in a patient hospitalized in Solano County, California ( 1 ). The patient was initially evaluated at hospital A on February 15; at that time, COVID-19 was not suspected, as the patient denied travel or contact with symptomatic persons. During a 4-day hospitalization, the patient was managed with standard precautions and underwent multiple aerosol-generating procedures (AGPs), including nebulizer treatments, bilevel positive airway pressure (BiPAP) ventilation, endotracheal intubation, and bronchoscopy. Several days after the patient’s transfer to hospital B, a real-time reverse transcription–polymerase chain reaction (real-time RT-PCR) test for SARS-CoV-2 returned positive. Among 121 hospital A health care personnel (HCP) who were exposed to the patient, 43 (35.5%) developed symptoms during the 14 days after exposure and were tested for SARS-CoV-2; three had positive test results and were among the first known cases of probable occupational transmission of SARS-CoV-2 to HCP in the United States. Little is known about specific risk factors for SARS-CoV-2 transmission in health care settings. To better characterize and compare exposures among HCP who did and did not develop COVID-19, standardized interviews were conducted with 37 hospital A HCP who were tested for SARS-CoV-2, including the three who had positive test results. Performing physical examinations and exposure to the patient during nebulizer treatments were more common among HCP with laboratory-confirmed COVID-19 than among those without COVID-19; HCP with COVID-19 also had exposures of longer duration to the patient. Because transmission-based precautions were not in use, no HCP wore personal protective equipment (PPE) recommended for COVID-19 patient care during contact with the index patient. Health care facilities should emphasize early recognition and isolation of patients with possible COVID-19 and use of recommended PPE to minimize unprotected, high-risk HCP exposures and protect the health care workforce. HCP with potential exposures to the index patient at hospital A were identified through medical record review. Hospital and health department staff members contacted HCP for initial risk stratification and classified HCP into categories of high, medium, low, and no identifiable risk, according to CDC guidance.* HCP at high or medium risk were furloughed and actively monitored; those at low risk were asked to self-monitor for symptoms for 14 days from their last exposure. † Nasopharyngeal and oropharyngeal specimens were collected once from HCP who developed symptoms consistent with COVID-19 § during their 14-day monitoring period, and specimens were tested for SARS-CoV-2 using real-time RT-PCR at the California Department of Public Health. Serologic testing and testing for other respiratory viruses was not performed. The investigation team, including hospital, local and state health departments, and CDC staff members, attempted to contact all 43 tested HCP by phone to conducted interviews regarding index patient exposures using a standardized exposure assessment tool. Two-sided p-values were calculated using Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous variables; p-values 60 1/3 (33) 3/34 (9) Median (IQR) total estimated time in patient room, mins 120 (120–420) 25 (10–50) 0.06 Median (IQR) total estimated time in patient room during AGPs, mins¶ 95 (0–160) 0 (0–3) 0.13 Came within 6 ft of index patient 3/3 (100) 30/34 (91) 1.00 Reported direct skin-to-skin contact with index patient 0/3 (0) 8/34 (24) 1.00 Index patient either masked or on closed-system ventilator when contact occurred Always 0/3 (0) 7/34 (23) 0.58 Sometimes 2/3 (67) 10/34 (32) Never 1/3 (33) 14/34 (45) Abbreviations: AGPs = aerosol-generating procedures; COVID-19 = coronavirus disease 2019; IQR = interquartile range. * Versus sometimes or never. † No HCP reported use of gowns, N95 respirators, powered air-purifying respirators (PAPRs), or eye protection during any patient care activities for index patient. § Denominators for PPE use during AGPs are numbers of HCP exposed to AGPs. ¶ This was estimated by asking each interviewed staff member to report the number and average duration of each exposure to the patient during AGPs. Total estimated duration for each AGP was calculated by multiplying the number of exposures by average duration of exposure during that AGP. Total estimated exposure time for all AGPs was calculated by adding total duration of exposures across all AGPs. Discussion HCP are at high risk for acquiring infections during novel disease outbreaks, especially before transmission dynamics are fully characterized. The cases reported here are among the first known reports of occupational transmission of SARS-CoV-2 to HCP in the United States, although more cases have since been identified ( 2 ). Little is known to date about SARS-CoV-2 transmission in health care settings. Reports from Illinois, Singapore, and Hong Kong have described cohorts of HCP exposed to patients with COVID-19 without any documented HCP transmission ( 3 – 5 ); most HCP exposures in these cases occurred with patients while HCP were using contact, droplet, or airborne precautions. §§ As community transmission of COVID-19 increases, determining whether HCP infections are acquired in the workplace or in the community becomes more difficult. This investigation presented a unique opportunity to analyze exposures associated with COVID-19 transmission in a health care setting without recognized community exposures. Describing exposures among HCP who did and did not develop COVID-19 can inform guidance on how to best protect HCP. Among a cohort of 121 exposed HCP, 43 of whom were symptomatic and tested, three developed confirmed COVID-19, despite multiple unprotected exposures among HCP. HCP who developed COVID-19 had longer durations of exposure to the index patient; exposures during nebulizer treatments and BiPAP were also more common among HCP who developed COVID-19. These findings underscore the heightened COVID-19 transmission risk associated with prolonged, unprotected patient contact and the importance of ensuring that HCP exposed to patients with confirmed or suspected COVID-19 are protected. CDC recommends use of N95 or higher-level respirators and airborne infection isolation rooms when performing AGPs for patients with suspected or confirmed COVID-19; for care that does not include AGPs, CDC recommends use of respirators where available. ¶¶ In California, the Division of Occupational Safety and Health Aerosol Transmissible Diseases standard requires respirators for HCP exposed to potentially airborne pathogens such as SARS-CoV-2; PAPRs are required during AGPs.*** Studies of other respiratory pathogens have documented increased transmission risk associated with AGPs, many of which can generate large droplets as well as small particle aerosols ( 6 ). A recent study found that SARS-CoV-2 generated through nebulization can remain viable in aerosols <5 μm for hours, suggesting that SARS-CoV-2 could be transmitted at least in part through small particle aerosols ( 7 ). Among the three HCP with COVID-19 at hospital A, two had index patient exposures during AGPs; one did not and reported wearing a facemask but no eye protection for most of the contact time with the patient. Given multiple unprotected exposures among HCP in this investigation, separating risks associated with specific procedures from those associated with duration of exposure and lack of recommended PPE is difficult. More research to determine the risks associated with specific procedures and the protectiveness of different types of PPE, as well as the extent of short-range aerosol transmission of SARS-CoV-2, is needed. Patient source control (e.g., patient wearing a mask or connected to a closed-system ventilator during HCP exposures) might also reduce risk of SARS-CoV-2 transmission. Although the index patient was not masked or ventilated for the majority of hospital A admission, at hospital B, where the patient remained on a closed system ventilator from arrival to receiving a positive test result, none of the 146 HCP identified as exposed developed known COVID-19 infection ( 8 ). Source control strategies, such as masking of patients, visitors, and HCP, should be considered by health care facilities to reduce risk of SARS-CoV-2 transmission. This findings in this report are subject to at least three limitations. First, exposures among HCP were self-reported and are subject to recall bias. Second, the low number of cases limits the ability to detect statistically significant differences in exposures and does not allow for multivariable analyses to adjust for potential confounding. Finally, additional infections might have occurred among asymptomatic exposed HCP who were not tested, or among HCP who were tested as a result of timing and limitations of nasopharyngeal and oropharyngeal specimen testing; serologic testing was not performed. To protect HCP caring for patients with suspected or confirmed COVID-19, health care facilities should continue to follow CDC, state, and local infection control and PPE guidance. Early recognition and prompt isolation, including source control, for patients with possible infection can help minimize unprotected and high-risk HCP exposures. These measures are crucial to protect HCP and preserve the health care workforce in the face of an outbreak already straining the U.S. health care system. Summary What is already known about this topic? Health care personnel (HCP) are at heightened risk of acquiring COVID-19 infection, but limited information exists about transmission in health care settings. What is added by this report? Among 121 HCP exposed to a patient with unrecognized COVID-19, 43 became symptomatic and were tested for SARS-CoV-2, of whom three had positive test results; all three had unprotected patient contact. Exposures while performing physical examinations or during nebulizer treatments were more common among HCP with COVID-19. What are the implications for public health practice? Unprotected, prolonged patient contact, as well as certain exposures, including some aerosol-generating procedures, were associated with SARS-CoV-2 infection in HCP. Early recognition and isolation of patients with possible infection and recommended PPE use can help minimize unprotected, high-risk HCP exposures and protect the health care workforce.
                Bookmark

                Author and article information

                Journal
                MMWR Morb Mortal Wkly Rep
                MMWR Morb Mortal Wkly Rep
                WR
                Morbidity and Mortality Weekly Report
                Centers for Disease Control and Prevention
                0149-2195
                1545-861X
                10 July 2020
                10 July 2020
                : 69
                : 27
                : 853-858
                Affiliations
                Health Systems and Worker Safety Task Force, CDC COVID-19 Response Team; Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC; Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, CDC.
                Author notes
                Corresponding author: Matthew R. Groenewold, mgroenewold@ 123456cdc.gov .
                Article
                mm6927a1
                10.15585/mmwr.mm6927a1
                7727595
                32644979
                1b0c8f88-b896-4532-b948-0a786abb3c93

                All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.

                History
                Categories
                Full Report

                Comments

                Comment on this article